Skip to main content
Clinical Trials/NCT02113254
NCT02113254
Completed
Not Applicable

Study of Modification of the Density of the Macular Pigment by the Consumption of Corn With Strong Content in Zeaxanthine

University Hospital, Bordeaux1 site in 1 country9 target enrollmentFebruary 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Age Macular Degeneration
Sponsor
University Hospital, Bordeaux
Enrollment
9
Locations
1
Primary Endpoint
The primary outcome is the measure of the evolution of the macular pigment density after 10 weeks of supplementation compared with the initial measure.
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

The Age Macular Degeneration (AMD) is the first cause of blindness in industrialized countries. The macular pigment (lutein and zeaxanthin) could play an important role in the arisen of the AMD. The food supplementation by corn with strong concentration in macular pigment could increase the density of the macular pigment. This could, in the future, represent a strategy of prevention of the AMD. The main objective of this study is to detect an increase of the macular pigment density after the consumption of this corn at healthy volunteers.

Detailed Description

The age macular degeneration represents the first cause of blindness in industrialized countries if it is not treated. In France, the AMD affects 600 000 persons and this figure should continue to increase, notably because of the increase of the life expectancy. The macula is responsible of the fine vision, the vision of colours and the perception of contrasts. The macular pigment is present only at the level of the macular area. This pigment is composed of three carotenoids: lutein, zeaxanthin, meso-zeaxanthin. The first two compounds are of strictly food origin and are not produced in an endogenous way. A change of the macular pigment density and/or the quality of the macular pigment is suspected to play a role in the appearance and the evolution of the AMD. The food supplementation by corn with strong concentration in macular pigment could increase the density of the macular pigment. This could, in the future, represent a strategy of prevention of the AMD. The main objective of this study is to detect an increase of the macular pigment density after the consumption of this corn at healthy volunteers. The treatment will consist in a daily consumption of a box of 125g of corn with strong zeaxanthin content during 10 weeks. This corresponds to a daily contribution of at least 1,2 mg of lutein and 2,2 mg de zeaxanthin. After the inclusion visit, the subject will be seen 5 times (after 3, 6, 8, 10, 14 weeks of treatment). In all these visits, measures of the macular pigment will be realized. A blood sample will be realized at the inclusion visit and during the visit at 6 and 10 weeks.

Registry
clinicaltrials.gov
Start Date
February 2014
End Date
June 2014
Last Updated
11 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
University Hospital, Bordeaux
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

The primary outcome is the measure of the evolution of the macular pigment density after 10 weeks of supplementation compared with the initial measure.

Time Frame: 10 weeks after inclusion

Secondary Outcomes

  • The measure of plasmatic rate of total cholesterol, HDL-cholesterol, triglycerides, lutein and zeaxanthin, initial and in 6 and 10 weeks of supplementation(10 weeks after inclusion)
  • In the inclusion, the measure of the retinal thickness with OCT (Optical Coherence Tomography)(10 weeks after inclusion)
  • The measure of the evolution of the plasmatic rate of zeaxanthin after10 weeks of supplementation(10 weeks after inclusion)
  • The measure of the macular pigment density before supplementation in 3, 6, 8, and 10 weeks of supplementation and after 4 weeks of stop by three methods: the sensibility in colours and two methods of autofluorescence(10 weeks after inclusion)
  • In the inclusion, the measure of the visual acuity and the examination of the fundus oculi.(10 weeks after inclusion)

Study Sites (1)

Loading locations...

Similar Trials